+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Blood Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Blood Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5952842
Free Webex Call
10% Free customization
Description Jump to:

Whole Blood is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Blood Management Market, valued at USD 13.62 Billion in 2024, is projected to experience a CAGR of 6.90% to reach USD 20.33 Billion by 2030. The global blood management market encompasses the comprehensive set of processes and technologies involved in ensuring a safe, adequate, and efficient blood supply from donor recruitment and collection to processing, testing, storage, and transfusion, including advanced patient blood management strategies. Key drivers supporting market expansion include the increasing incidence of chronic diseases requiring transfusions, a rising volume of surgical procedures worldwide, and the growing elderly population predisposed to conditions necessitating blood products.

Key Market Drivers

The rising prevalence of chronic diseases and blood disorders profoundly drives demand within the global blood management market. Conditions such as sickle cell disease, thalassemia, and various cancers necessitate frequent transfusions and specialized blood products for patient survival and improved quality of life. For example, according to Frontiers in Public Health, August 27, 2024, "Sickle cell disease: a comparative perspective on global and national initiatives," approximately 300,000 infants are born annually with Sickle Cell Disease globally, primarily in sub-Saharan Africa, India, and the Middle East, establishing a continuous requirement for blood components. This pervasive need creates an expanding base for the blood management sector.

Key Market Challenges

A critical challenge impeding the growth of the global blood management market stems from the consistent need to maintain a sufficient and safe blood supply. This challenge is exacerbated by evolving donor demographics and increasingly stringent regulatory requirements, directly impacting the ability of blood establishments to sustain robust donor recruitment and retention programs. The fluctuations in donor availability necessitate significant operational investments in outreach and educational initiatives, diverting resources that could otherwise be allocated to market expansion or technological advancements.

Key Market Trends

The shift towards personalized blood management strategies represents a significant evolution in patient care, moving beyond standardized transfusion protocols to tailored interventions based on individual patient needs. This approach focuses on optimizing a patient's own blood health, minimizing unnecessary transfusions, and thereby reducing associated risks such as infections and adverse reactions. For instance, according to an AABB review of current advances in 2024, treating iron deficiency anemia with intravenous iron significantly reduced postoperative red blood cell transfusions by 70%, improving patient outcomes. This trend influences the market by driving demand for advanced diagnostic tools to assess patient-specific factors like anemia and coagulation status, along with pharmacological alternatives to blood

Key Market Players Profiled:

  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • Immucor, Inc.
  • B Braun Melsungen AG
  • bioMérieux Inc.
  • Kaneka Corporation
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Blood Management Market has been segmented into the following categories:

By Product:

  • Instruments
  • Accessories
  • Reagents & Kits
  • Software

By Component:

  • Whole Blood
  • Red Blood Cells
  • Plasma

By End User:

  • Blood Banks
  • Hospitals
  • Diagnostic Clinics
  • Pathology Labs

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Management Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Blood Management Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Accessories, Reagents & Kits, Software)
5.2.2. By Component (Whole Blood, Red Blood Cells, Plasma)
5.2.3. By End User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Blood Management Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Component
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood Management Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Component
6.3.1.2.3. By End User
6.3.2. Canada Blood Management Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Component
6.3.2.2.3. By End User
6.3.3. Mexico Blood Management Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Component
6.3.3.2.3. By End User
7. Europe Blood Management Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Component
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Blood Management Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Component
7.3.1.2.3. By End User
7.3.2. France Blood Management Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Component
7.3.2.2.3. By End User
7.3.3. United Kingdom Blood Management Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Component
7.3.3.2.3. By End User
7.3.4. Italy Blood Management Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Component
7.3.4.2.3. By End User
7.3.5. Spain Blood Management Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Component
7.3.5.2.3. By End User
8. Asia-Pacific Blood Management Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Component
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Blood Management Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Component
8.3.1.2.3. By End User
8.3.2. India Blood Management Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Component
8.3.2.2.3. By End User
8.3.3. Japan Blood Management Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Component
8.3.3.2.3. By End User
8.3.4. South Korea Blood Management Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Component
8.3.4.2.3. By End User
8.3.5. Australia Blood Management Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Component
8.3.5.2.3. By End User
9. Middle East & Africa Blood Management Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Component
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Blood Management Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Component
9.3.1.2.3. By End User
9.3.2. UAE Blood Management Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Component
9.3.2.2.3. By End User
9.3.3. South Africa Blood Management Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Component
9.3.3.2.3. By End User
10. South America Blood Management Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Component
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood Management Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Component
10.3.1.2.3. By End User
10.3.2. Colombia Blood Management Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Component
10.3.2.2.3. By End User
10.3.3. Argentina Blood Management Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Component
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Blood Management Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Haemonetics Corporation
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Fresenius SE & Co. KGaA
15.3. Terumo Corporation
15.4. Immucor, Inc.
15.5. B Braun Melsungen AG
15.6. bioMérieux Inc.
15.7. Kaneka Corporation
15.8. Bio-Rad Laboratories, Inc.
15.9. Grifols, S.A.
15.10. F. Hoffmann-La Roche Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Blood Management market report include:
  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • Immucor, Inc.
  • B Braun Melsungen AG
  • bioMérieux Inc.
  • Kaneka Corporation
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • F. Hoffmann-La Roche Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 13.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.33 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Patient Blood Management: Market Share, and Growth Analysis by Product Type (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), Application, End User, Technology - Product Image

Patient Blood Management: Market Share, and Growth Analysis by Product Type (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Blood Bank Management Software Market - Global Forecast 2025-2032 - Product Image

Blood Bank Management Software Market - Global Forecast 2025-2032

  • Report
  • 182 Pages
  • Global
From
Blood Bank Market Report and Forecast 2025-2034 - Product Image

Blood Bank Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Blood Preparation Market - Global Forecast 2025-2032 - Product Image

Blood Preparation Market - Global Forecast 2025-2032

  • Report
  • 187 Pages
  • Global
From
Blood Product Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Product Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.